Education
About Us
Working with TipRanks
Follow Us
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Total Valuation
KYORIN Pharmaceutical Co.,Ltd. has a market cap or net worth of ¥78.96B. The enterprise value is ¥92.97B.
Market Cap¥78.96B
Enterprise Value¥92.97B
Share Statistics
KYORIN Pharmaceutical Co.,Ltd. has 59,945,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,945,640
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
KYORIN Pharmaceutical Co.,Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.37%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.37%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee63.71M
Profits Per Employee4.45M
Employee Count2,042
Asset Turnover0.67
Inventory Turnover1.07
Valuation Ratios
The current PE Ratio of KYORIN Pharmaceutical Co.,Ltd. is 9.50. KYORIN Pharmaceutical Co.,Ltd.’s PEG ratio is 0.07.
PE Ratio9.50
PS Ratio0.00
PB Ratio0.63
Price to Fair Value0.63
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.07
Income Statement
In the last 12 months, KYORIN Pharmaceutical Co.,Ltd. had revenue of 130.09B and earned 9.09B in profits. Earnings per share was 158.16.
Revenue130.09B
Gross Profit59.51B
Operating Income12.55B
Pretax Income12.77B
Net Income9.09B
EBITDA17.55B
Earnings Per Share (EPS)158.16
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
KYORIN Pharmaceutical Co.,Ltd. pays an annual dividend of ¥57, resulting in a dividend yield of 0.67%
Dividend Per Share¥57
Dividend Yield0.67%
Payout Ratio15.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change-8.57%
50-Day Moving Average1.48K
200-Day Moving Average1.46K
Relative Strength Index (RSI)55.00
Average Volume (3m)101.31K
Important Dates
KYORIN Pharmaceutical Co.,Ltd. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateSep 29, 2025
Financial Position
KYORIN Pharmaceutical Co.,Ltd. as a current ratio of 3.88, with Debt / Equity ratio of 20.87%
Current Ratio3.88
Quick Ratio2.01
Debt to Market Cap0.32
Net Debt to EBITDA0.76
Interest Coverage Ratio72.53
Taxes
In the past 12 months, KYORIN Pharmaceutical Co.,Ltd. has paid 3.68B in taxes.
Income Tax3.68B
Effective Tax Rate0.29
Enterprise Valuation
KYORIN Pharmaceutical Co.,Ltd. EV to EBITDA ratio is 5.68, with an EV/FCF ratio of -45.51.
EV to Sales0.77
EV to EBITDA5.68
EV to Free Cash Flow-45.51
EV to Operating Cash Flow28.44
Balance Sheet
KYORIN Pharmaceutical Co.,Ltd. has ¥15.51B in cash and marketable securities with ¥32.59B in debt, giving a net cash position of ¥17.07B billion.
Cash & Marketable Securities¥15.51B
Total Debt¥32.59B
Net Cash¥17.07B
Net Cash Per Share¥284.82
Tangible Book Value Per Share¥2.37K
Margins
Gross margin is 45.76%, with operating margin of 9.65%, and net profit margin of 6.98%.
Gross Margin45.76%
Operating Margin9.65%
Pretax Margin9.82%
Net Profit Margin6.98%
EBITDA Margin13.49%
EBIT Margin9.95%
Analyst Forecast
The average price target for KYORIN Pharmaceutical Co.,Ltd. is ¥1,629.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥1,629.00
Price Target Upside8.60% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast8.83%
EPS Growth Forecast70.61%